Article
Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients
4 Feb 2021
Abstract excerpt
BACKGROUND: Analysis of cell-free tumour DNA, a liquid biopsy, is a promising biomarker for cancer. We have performed a proof-of principle study to test the applicability in the clinical setting, analysing copy number alterations (CNAs) in plasma and tumour tissue from 44 patients with gastro-oesophageal cancer. METHODS: DNA was isolated from blood plasma and a tissue sample from each patient. Array-CGH was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
